340B INDUSTRY LEADER SPOTLIGHT

Jamila (“Jam”) Seibel, Director, Alinea Group

Jam Seibel
Q: Where did you grow up?

Clifton Park, New York, a small suburb upstate, between Albany and Saratoga Springs, NY.

Read More »

Exclusive

HRSA Says COVID Flexibility About Dispensing 340B Drugs in Unregistered Hospital Offsite Locations Will End Thursday

COVID-19 flexibility
HRSA has reversed course and will end a 340B COVID-19 flexibility that it previously said was permanent that lets hospitals under certain conditions start using 340B drugs at offsite outpatient locations sooner than HRSA would normally allow.

The U.S. Health Resources and Services Administration said late Friday that when the COVID-19 public health emergency ends on Thursday, so too will a nearly three-year-old policy clarification that lets hospitals under certain conditions dispense 340B drugs at offsite outpatient

Read More »

In Shift, 340B Health and AHA Now Say They Back Congressional Action on 340B Contract Pharmacy

Doris Matsui
340B Health and the AHA say they support 340B contract pharmacy legislation that Rep. Doris Matsui (D-Calif.) is working on.

Hospital group 340B Health and the American Hospital Association both have decided to support federal legislation to prohibit drug manufacturer restrictions on 340B covered entities’ use of contract pharmacies. A senior AHA official was quoted in a news article just

Read More »

340B Sales Growth Rate Softened for Second Straight Year, Data Show

IQVIA
Prescription drug sales at 340B prices softened for the second consecutive year compared with sales growth from 2019 to 2020, data in a new IQVIA white paper show.

Prescription drug sales at 340B prices grew 12.2% year-on-year from 2021 to 2022, drug industry consulting and research firm IQVIA says in a new white paper. That is down 3.7 percentage points compared with 340B sales growth from 2020

Read More »

340B Health Centers Urge N.Y. State Trial Court to Block Medicaid Pharmacy Transfer

New York
Two New York health centers are seeking a preliminary injunction against the state's shift of Medicaid managed care pharmacy benefits to Medicaid fee for service.

Two New York health centers have filed a new request with a state trial court to stop a recently launched state pharmacy benefit transfer, which the plaintiffs argue will cost providers millions in annual 340B revenue.

The April 26

Read More »

Ex-GOP Congressman Burton Slams Current GOP Rep. Rosendale’s 340B Bill

Dan Burton
Retired U.S. Rep. Dan Burton (R-Ind.) lauded the 340B program and criticized a current GOP congressman's 340B bill in a newspaper op-ed this week.

Former Republican Congressman Dan Burton (Ind.) called the 340B program “a win for all parties involved” in a Kokomo, Indiana newspaper op-ed this week and said a current House Republican’s 340B bill could deny vulnerable Hoosiers access to care.

Rep.

Read More »

Exelixis Puts 45-Day Limit on Requests to Reclassify Past Sales as 340B Purchases

Exelixis
Exelixis says starting May 15 it will honor 340B covered entities' requests to replenish/reclassify prior purchases that were not made at the 340B ceiling price only within 45 days of the date that the drug was dispensed.

Starting May 15, biopharmaceutical manufacturer Exelixis will require 340B covered entities that want past drug purchases that were not made at the 340B ceiling price to be reclassified as 340B sales to do so within 45 days of the date

Read More »

340B INDUSTRY LEADER SPOTLIGHT

Anthony Esgro, Director of 340B Programs, Signify Health

Anthony Esgro
Q: Where did you grow up?

I was born, raised and still reside in Glassboro NJ. It’s about 20 minutes east of Philadelphia in southern New Jersey.

Read More »

Expert Tip From Avita Care Solutions

img
img

TIP: If your entity engages a firm to independently audit your 340B Program, follow through on the auditor’s recommendations in a timely manner.

Read More »

340B-Related Amendment Might Be Offered to PBM Reform Bill That Senate Panel Is Trying to Mark Up Today

Mike Braun
Sen. Mike Braun (R-Ind.) is expected offer an amendment in committee today to PBM reform legislation to require 340B hospitals to be more transparent about how they use 340B program savings.

A U.S. Senate committee is attempting to mark up bipartisan legislation today to reform the pharmacy benefit management industry. The draft bill itself does not address the 340B program. Republican Sen. Mike Braun (Ind.), however, has filed an amendment for

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live